Cite
HARVARD Citation
Brogan, P. et al. (2022). Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis. Arthritis & rheumatology. 74 (1), pp. 124-133. [Online].